Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Neoplasms × epacadostat × Thoracic × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gynecologic 2 Tumor-Agnostic 1 Thoracic 1

Conditions

Carcinoma, Non-Small-Cell Lung 10 Lung Neoplasms 6 Melanoma 5 Parkinson Disease 4, Autosomal Dominant Lewy Body 4 Squamous Cell Carcinoma of Head and Neck 3 Ovarian Neoplasms 3 Head and Neck Neoplasms 3 Colorectal Neoplasms 3 Triple Negative Breast Neoplasms 2 Stomach Neoplasms 2 Small Cell Lung Carcinoma 2 Lymphoma 2 Endometrial Neoplasms 2 Carcinoma, Transitional Cell 2 Carcinoma, Renal Cell 2 Carcinoma, Hepatocellular 2 Uterine Cervical Neoplasms 1 Urinary Bladder Neoplasms 1 Thymus Neoplasms 1 Thymoma 1 Neoplasms 1 Neoplasm Metastasis 1 Microsatellite Instability 1 Mesothelioma 1 Glioblastoma 1 Extensive Stage Small Cell Lung Carcinoma 1 Esophageal Neoplasms 1 Carcinoma, Merkel Cell 1

Interventions

pembrolizumab 54 Carboplatin 41 Docetaxel 30 Pemetrexed 29 Paclitaxel 29 Cisplatin 26 Nivolumab 22 Gemcitabine 21 Erlotinib Hydrochloride 19 Bevacizumab 16 Ipilimumab 10 osimertinib 9 atezolizumab 9 Radiosurgery 9 Drug Therapy 9 Cyclophosphamide 9 Cetuximab 9 Radiotherapy 8 Blood Specimen Collection 8 durvalumab 7 budigalimab 7 Dexamethasone 7 trametinib 6 fludarabine 6 cemiplimab 6 Taxes 6 Fluorouracil 6 130-nm albumin-bound paclitaxel 6 rovalpituzumab tesirine 5 avelumab 5

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02862457 2022-08-19

MK-3475-434

Merck Sharp & Dohme LLC

Phase 1 Completed

34 enrolled 25 charts

Carcinoma, Non-Small-Cell Lung, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡